Idarucizumab

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects

Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State

Reversal of Dabigatran Anticoagulant Effect With Idarucizumab

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

CU Programme of Idarucizumab for Japanese Patients

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients